Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XVENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XVENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.377EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.377EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.377ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.377ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.377EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.377EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.377ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.377ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.15EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.258.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.15ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.258.15ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.258.15EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.258.15EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.258.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.298EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.298EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.298ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.298ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.298EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.298EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.298ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.298ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.30.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.30.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.30.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
C.30.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
C.30.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
C.30.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
C.30.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.30.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.76EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.76EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.76ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.76ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.76EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.76EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.76ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.76ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.17.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.17.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.17.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.17.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.17.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.17.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.17.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.17.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used